Literature DB >> 27593185

Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.

Ami Mankodi1, Courtney A Bishop2, Sungyoung Auh3, Rexford D Newbould2, Kenneth H Fischbeck3, Robert L Janiczek4.   

Abstract

The purpose of this study was to explore the use of iterative decomposition of water and fat with echo asymmetry and least-squares estimation Carr-Purcell-Meiboom-Gill (IDEAL-CPMG) to simultaneously measure skeletal muscle apparent fat fraction and water T2 (T2,w) in patients with Duchenne muscular dystrophy (DMD). In twenty healthy volunteer boys and thirteen subjects with DMD, thigh muscle apparent fat fraction was measured by Dixon and IDEAL-CPMG, with the IDEAL-CPMG also providing T2,w as a measure of muscle inflammatory activity. A subset of subjects with DMD was followed up during a 48-week clinical study. The study was in compliance with the Patient Privacy Act and approved by the Institutional Review Board. Apparent fat fraction in the thigh muscles of subjects with DMD was significantly increased compared to healthy volunteer boys (p <0.001). There was a strong correlation between Dixon and IDEAL-CPMG apparent fat fraction. Muscle T2,w measured by IDEAL-CPMG was independent of changes in apparent fat fraction. Muscle T2,w was higher in the biceps femoris and vastus lateralis muscles of subjects with DMD (p <0.05). There was a strong correlation (p <0.004) between apparent fat fraction in all thigh muscles and six-minute walk distance (6MWD) in subjects with DMD. IDEAL-CPMG allowed independent and simultaneous quantification of skeletal muscle fatty degeneration and disease activity in DMD. IDEAL-CPMG apparent fat fraction and T2,w may be useful as biomarkers in clinical trials of DMD as the technique disentangles two competing biological processes. Published by Elsevier B.V.

Entities:  

Keywords:  Apparent fat fraction; Duchenne muscular dystrophy; Fatty degeneration; IDEAL-CPMG; Magnetic resonance imaging; Skeletal muscle; T(2) relaxation times; Water T(2)

Mesh:

Substances:

Year:  2016        PMID: 27593185      PMCID: PMC5062949          DOI: 10.1016/j.nmd.2016.07.013

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

1.  Cramér-Rao bounds for three-point decomposition of water and fat.

Authors:  Angel R Pineda; Scott B Reeder; Zhifei Wen; Norbert J Pelc
Journal:  Magn Reson Med       Date:  2005-09       Impact factor: 4.668

2.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

3.  Simultaneous T₂ and lipid quantitation using IDEAL-CPMG.

Authors:  Robert L Janiczek; Giulio Gambarota; Christopher D J Sinclair; Tarek A Yousry; John S Thornton; Xavier Golay; Rexford D Newbould
Journal:  Magn Reson Med       Date:  2011-05-20       Impact factor: 4.668

4.  Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.

Authors:  Claire Wary; Noura Azzabou; Céline Giraudeau; Julien Le Louër; Marie Montus; Thomas Voit; Laurent Servais; Pierre Carlier
Journal:  NMR Biomed       Date:  2015-07-27       Impact factor: 4.044

5.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.

Authors:  R J Willcocks; I A Arpan; S C Forbes; D J Lott; C R Senesac; E Senesac; J Deol; W T Triplett; C Baligand; M J Daniels; H L Sweeney; G A Walter; K Vandenborne
Journal:  Neuromuscul Disord       Date:  2014-01-11       Impact factor: 4.296

6.  Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Monika Gloor; Maurice Schmid; Andrea Klein; Urs Pohlman; Tanja Waltz; Rocio Gonzalez; Tanja Haas; Oliver Bieri; Dirk Fischer
Journal:  J Neurol       Date:  2012-11-09       Impact factor: 4.849

7.  Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months.

Authors:  Kieren G Hollingsworth; Penny Garrood; Michelle Eagle; Kate Bushby; Volker Straub
Journal:  Muscle Nerve       Date:  2013-08-30       Impact factor: 3.217

8.  Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study.

Authors:  Thomas Voit; Haluk Topaloglu; Volker Straub; Francesco Muntoni; Nicolas Deconinck; Giles Campion; Sjef J De Kimpe; Michelle Eagle; Michela Guglieri; Steve Hood; Lia Liefaard; Afrodite Lourbakos; Allison Morgan; Joanna Nakielny; Naashika Quarcoo; Valeria Ricotti; Katie Rolfe; Laurent Servais; Claire Wardell; Rosamund Wilson; Padraig Wright; John E Kraus
Journal:  Lancet Neurol       Date:  2014-09-07       Impact factor: 44.182

9.  The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine M Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart Peltz
Journal:  Muscle Nerve       Date:  2013-06-26       Impact factor: 3.217

10.  Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.

Authors:  Sean C Forbes; Rebecca J Willcocks; William T Triplett; William D Rooney; Donovan J Lott; Dah-Jyuu Wang; Jim Pollaro; Claudia R Senesac; Michael J Daniels; Richard S Finkel; Barry S Russman; Barry J Byrne; Erika L Finanger; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  PLoS One       Date:  2014-09-09       Impact factor: 3.240

View more
  21 in total

1.  Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy.

Authors:  Ami Mankodi; Noura Azzabou; Thomas Bulea; Harmen Reyngoudt; Hirity Shimellis; Yupeng Ren; Eunhee Kim; Kenneth H Fischbeck; Pierre G Carlier
Journal:  Neuromuscul Disord       Date:  2017-04-28       Impact factor: 4.296

2.  Quantitative T2 -mapping magnetic resonance imaging for assessment of muscle motor unit recruitment patterns.

Authors:  Erin C Argentieri; Ek Tsoon Tan; Jeremy S Whang; Sophie C Queler; Joseph H Feinberg; Bin Lin; Darryl B Sneag
Journal:  Muscle Nerve       Date:  2021-02-12       Impact factor: 3.217

3.  MRI correlates of motoneuron loss in SMA.

Authors:  Alina Sprenger-Svačina; Johannes Haensch; Kilian Weiss; Nils Große Hokamp; David Maintz; Marc Schlamann; Gereon R Fink; Natalie Schloss; Kai Laukamp; Gilbert Wunderlich; Helmar C Lehmann; Thorsten Lichtenstein
Journal:  J Neurol       Date:  2022-10-01       Impact factor: 6.682

4.  Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases.

Authors:  Harmen Reyngoudt; Benjamin Marty; Jean-Marc Boisserie; Julien Le Louër; Cedi Koumako; Pierre-Yves Baudin; Brenda Wong; Tanya Stojkovic; Anthony Béhin; Teresa Gidaro; Yves Allenbach; Olivier Benveniste; Laurent Servais; Pierre G Carlier
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

5.  Pericytes in Muscular Dystrophies.

Authors:  Louise Anne Moyle; Francesco Saverio Tedesco; Sara Benedetti
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

6.  MR biomarkers predict clinical function in Duchenne muscular dystrophy.

Authors:  Alison M Barnard; Rebecca J Willcocks; William T Triplett; Sean C Forbes; Michael J Daniels; Saptarshi Chakraborty; Donovan J Lott; Claudia R Senesac; Erika L Finanger; Ann T Harrington; Gihan Tennekoon; Harneet Arora; Dah-Jyuu Wang; H Lee Sweeney; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Neurology       Date:  2020-02-05       Impact factor: 9.910

Review 7.  Rotator cuff tear degeneration and the role of fibro-adipogenic progenitors.

Authors:  Obiajulu Agha; Agustin Diaz; Michael Davies; Hubert T Kim; Xuhui Liu; Brian T Feeley
Journal:  Ann N Y Acad Sci       Date:  2020-07-29       Impact factor: 5.691

8.  Improved nerve conspicuity with water-weighting and denoising in two-point Dixon magnetic resonance neurography.

Authors:  Ek T Tan; Sophie C Queler; Bin Lin; Yoshimi Endo; Alissa J Burge; Julia Sternberg; Hollis G Potter; Darryl B Sneag
Journal:  Magn Reson Imaging       Date:  2021-03-20       Impact factor: 3.130

9.  Quantitative muscle MRI biomarkers in Duchenne muscular dystrophy: cross-sectional correlations with age and functional tests.

Authors:  Sarah P Sherlock; Yao Zhang; Michael Binks; Shannon Marraffino
Journal:  Biomark Med       Date:  2021-06-22       Impact factor: 2.851

10.  Magnetic Resonance Imaging Studies in Duchenne Muscular Dystrophy: Linking Findings to the Physical Therapy Clinic.

Authors:  Claudia R Senesac; Alison M Barnard; Donovan J Lott; Kavya S Nair; Ann T Harrington; Rebecca J Willcocks; Kirsten L Zilke; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  Phys Ther       Date:  2020-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.